Georgia’s new ban on abortion after six weeks will create a “very tight timeframe” for pregnant people to obtain a legal abortion, says Dean Rebouche. Read More

Dean Rebouche notes that Walgreens’ approach to dispensing abortion pills is necessarily cautious, given the “dynamic and frankly confusing legal landscape.” Read More

Dean Rebouche says the furor over Walgreens’ decision not to dispense abortion pills in some states where they are legal is “what we are in store for” as conflict centers on access to the medication. Read More

Could a Texas judge block access to abortion pills nationwide? Dean Rebouche discusses a new lawsuit and explains what’s at stake. Read More

Dean Rebouche explains what’s at stake in conflicting opinions over the FDA’s authority to approve mifepristone, and how the issue could impact federal agencies across the board. Read More

The FDA should decline to enforce a mifepristone ban, argue Dean Rebouche and co-authors David S. Cohen and Greer Donley in this Guardian op-ed. Read More

Dean Rebouche joins Background Briefing to discuss why she thinks the FDA should decline to enforce any ban on mifepristone. Read More

Dean Rachel Rebouche says an appellate court ruling on access to abortion pills has added confusion, putting the issue in “uncharted territory.” Read More

Dean Rebouche joined the National Constitution Center’s We the People podcast to discuss the legality of abortion pills. Read More

Dean Rebouche weighs the Supreme Court’s options on access to mifepristone while the appeals process plays out. Read More